Saito Go, Jinta Torahiko, Nakaoka Hiroshi, Kitamura Atsushi, Yamaguchi Kenichi, Nishimura Naoki
Division of Pulmonary Medicine, St. Luke's International Hospital, Japan.
Department of Pulmonary Medicine, Seirei Hamamatsu General Hospital, Japan.
Intern Med. 2017;56(12):1549-1552. doi: 10.2169/internalmedicine.56.7985. Epub 2017 Jun 15.
Small cell lung cancer (SCLC) is a neuroendocrine tumor, and the median age of onset is about 70 years old. A 20-year-old non-smoking man with known systemic sclerosis presented with discomfort in his left chest. Chest X-ray showed a mass shadow in the left upper zone. A transbronchial lung biopsy revealed small cell carcinoma, and imaging studies reached the diagnosis of extensive disease small cell lung cancer. He had concurrent interstitial lung disease with a non-specific interstitial pneumonia pattern and anti-Scl-70 antibodies. He died eight months after the diagnosis during fifth-line chemotherapy. We herein report the youngest case to date of SCLC with systemic sclerosis.
小细胞肺癌(SCLC)是一种神经内分泌肿瘤,发病年龄中位数约为70岁。一名20岁的非吸烟男性,已知患有系统性硬化症,出现左胸不适。胸部X线显示左上区有肿块阴影。经支气管肺活检显示为小细胞癌,影像学检查确诊为广泛期小细胞肺癌。他同时患有间质性肺病,表现为非特异性间质性肺炎模式,且存在抗Scl-70抗体。他在诊断后八个月的第五线化疗期间死亡。我们在此报告迄今为止最年轻的合并系统性硬化症的小细胞肺癌病例。